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Abstract
Bacterial strains isolated from US domestic honey were screened for antibacterial
activity against Paenibacillus larvae ssp. larvae, the causative agent of American
Foulbrood (AFB) in apiaries. A bacterial isolate (TH13) showing a high level of
antimicrobial activity against P. larvae ssp. larvae ATCC 9545 was selected and
identified as Paenibacillus polymyxa by 16S rRNA gene sequencing. The antimi-
crobial compound was purified by 80% saturated ammonium sulfate precipitation
followed by CM-sepharose chromatography and reverse-phase HPLC. The mole-
cular mass of the compound was determined to be 1168.78Da by ESI-qTOF MS,
matching that of polymyxin E1. The producer strain showed a broad range of
antibacterial activity against Gram-positive and -negative bacteria including
P. larvae ssp. larvae ATCC 25747 and foodborne pathogens such as Bacillus cereus
F4552 and Escherichia coli O157:H7 ATCC 43895. The selection of antibiotic-
producing bacterial strains indigenous to honey as protective cultures against AFB
may lessen the use of antibiotics in apiaries.
Introduction
A spore-forming bacterium, Paenibacillus larvae ssp. larvae,
is established to cause American Foulbrood (AFB), which
results in the annihilation of honeybee (Apis mellifera L.)
larvae and pupae, consequently devastating infected apiaries
(Shimanuki, 1990). AFB-infected apiaries suffer from severe
economic losses, resulting from significant decreases in
honeybee populations and honey production. In addition,
P. larvae-contaminated honey represents a risk for further
spread of this devastating disease (Antu´nez et al., 2004).
Current control methods include burning contaminated
honeybee colonies or treatment of colonies with antibiotics
(Shimanuki, 1990). However, the use of antibiotics such as
tetracycline and its derivatives to treat AFB can result in the
contamination of honey with residual antibiotics (Khong
et al., 2005; Martel et al., 2006). Chloramphenicol has been
detected in honey and other apiary products in numerous
countries (Nakajima et al., 1997; Bogusz et al., 2004;
Bogdanov, 2006; Sheridan et al., 2008). Consequently, the
residues of antibiotics in bee products may cause potentially
lethal allergenic reactions or serious side effects in hypersen-
sitive consumers. An additional concern with prolonged use
of antibiotics in apiaries is the emergence of antibiotic-
resistant P. larvae strains. It has been reported that P. larvae
ssp. larvae isolates from AFB-infected sources exhibited
resistance to tetracyclines, the primary antibiotics used to
prevent and control AFB (Alippi et al., 2007). Recently,
resistance to tetracyclines was elucidated to be due to the
existence of a cryptic plasmid in P. larvae, and the repetitive
use of tetracyclines in vitro could induce resistant P. larvae
strains (Alippi et al., 2007).
Honeybee-associated sources have been tested for their
antagonist activity against P. larvae ssp. larvae. Propolis was
tested in vivo to cure AFB (Lindenfelser, 1968) and the
activities of Brazilian and US propolis against P. larvae ssp.
larvae were investigated by comparison with the conven-
tional antibiotics (Bastos et al., 2008). It was also reported
that mid-gut extracts of adult honeybees were assayed to
determine their antibacterial activity against wild P. larvae
ssp. larvae (Riessberger-Galle´ et al., 2001). Recently, bacter-
ial isolates from honeybee larvae were identified and eval-
uated to determine their antibacterial activity against AFB
disease (Evans & Armstrong, 2006). In addition, aerobic
spore-forming bacteria from honeys and apiarian sources
were investigated to evaluate their antagonistic activity
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against P. larvae ssp. larvae (Alippi & Reynaldi, 2006). Most
of the isolates were identified as Bacillus spp. and exhibited
very strong activity against the honeybee pathogen. Evans &
Lopez (2004) fed nonpathogenic bacteria to honeybee larvae
as probiotic cultures to induce an immune response through
the upregulated expression of two antibacterial peptides.
In a previous study, we isolated bacterial strains from
eight different varieties of honey active against common
food spoilage and pathogenic microorganisms (Lee et al.,
2008a). Subsequently, characterization of antifungal com-
pounds produced by a bacterial isolate from honey has been
conducted (Lee et al., 2008b). In this study, indigenous
microbiota from US domestic honey samples were screened
for the production of the antimicrobial compounds active
against P. larvae ssp. larvae in an attempt to identify
potential protective cultures against AFB. As a potential
AFB control method, protective bacterial cultures isolated
from healthy honeybee colonies could be used to provide
‘natural’ protection against P. larvae ssp. larvae. Paenibacil-
lus polymyxa TH13, a bacterial isolate from honey, was
found to exhibit a high level of inhibitory activity against
P. larvae ssp. larvae and the antibacterial compound was
purified and characterized.
Materials and methods
Screening of honey bacterial stains
Bacterial strains were isolated from a US domestic honey
and screened for the production of antimicrobial activity
against P. larvae ssp. larvae. Briefly, honey was harvested
from healthy hives without AFB in New York State. One
gram of the honey sample was added to 1mL of sterile
deionized water to make a 50% honey solution. One
hundred microliters of the solution was spread onto tryptic
soy agar (TSA; Hardy Diagnostics, Santa Maria, CA) plates
and incubated at 30 1C for 24 h. The isolates were replica
plated onto TSA plates and preserved at 4 1C for further
study. All of the isolates were stored in 15% (v/v) glycerol at
 80 1C.
Antibacterial activity assay of bacterial isolates
Antibacterial activity of the honey bacterial isolates was
tested by deferred inhibition assay (Harding & Shaw, 1990).
The isolates were replica plated onto TSA plates and
incubated at 30 1C for 48 h. As an indicator bacterium,
P. larvae ssp. larvae ATCC 9545 was grown in American
Type Culture Collection (ATCC) medium 540 [brain heart
infusion (BHI; BD, Sparks, MD) supplemented with 1mg of
thiamine hydrochloride (Acros Organics, Morris Plains, NJ)
per liter of BHI] at 30 1C for 24 h. Molten soft ATCC
medium 540 [0.75% (w/v) agar] was mixed with the culture
[1% (v/v) inoculum] of the indicator and overlaid onto the
plates containing the bacterial isolates. The solidified plates
were incubated at 30 1C until the zones of inhibition were
discernible. The inhibition zones were then measured and
recorded for comparison of activities.
Identification of the producer strains
A bacterial isolate (TH13) displaying a high level of anti-
microbial activity was selected for further characterization
of the antimicrobial compound produced by this strain.
Gram staining and 16S rRNA gene sequencing was con-
ducted to identify the producer strain. Chromosomal DNA
was prepared based on the method described by Mengaud
et al. (1991). The chromosomal DNA of the isolate was used
as a template for PCR, with primers designed from the
conserved sequence in 16S rRNA genes of bacteria. A set of
primers, 16S-FOR (50-AGAGTTTGATCCTGGCTCAG-30)
and 16S-REV (50-AAGGAGGTGATCCAGCCGCA-30), were
used to amplify the region of interest. The PCR mixture was
heated at 94 1C for 3min for one cycle and subjected to 30
cycles of 1min of denaturation at 94 1C, 2min of annealing
at 37 1C, and 1.5min of polymerization at 72 1C, followed by
one cycle of 72 1C for 8min. The PCR product was run onto
0.7% (w/v) agarose gel and the amplified corresponding
band of the conserved sequence was extracted using QIA-
quick Gel Extraction Kit (Qiagen Inc., Valencia, CA) as per
the manufacturer’s instructions. Sequencing of the fragment
was conducted on the Applied Biosystems Automated 3730
DNA analyzer (Foster City, CA) at the Biotechnology
Resource Center, Cornell University (Ithaca, NY). The
DNA sequences were analyzed using the NCBI BLAST homol-
ogy search to identify the genus and species of the isolate.
Purification of the antibacterial compound
The producer strain (TH13) was inoculated into 200mL of
tryptic soy broth (TSB; BD) and grown at 30 1C with
agitation (250 r.p.m.) for 36 h. The culture supernatant was
recovered by centrifugation at 15 000 g for 10min at 4 1C.
The antibacterial compound was precipitated by the addi-
tion of ammonium sulfate (80% saturation) to the culture
supernatant. The precipitate was resuspended in sterile
deionized water and loaded onto CM-Sepharose Fast Flow
(GE Healthcare, Piscataway, NJ), and equilibrated with
buffer A [50mM Tris-Cl (pH 8.0)]. The cation-exchange
chromatography was eluted with buffer A, 0.5M NaCl in
buffer A, and 1.0M NaCl in buffer A sequentially. The
pooled active fractions from the cation exchanger were
injected onto an HPLC system (Agilent 1100 series, Agilent
Technologies, Wilmington, DE) equipped with a C18 re-
verse-phase column [Discovery Bio Wide pore C18 (5 mm,
4.6 150 cm), Supelco, Bellefonte, PA]. The antimicrobial
compound was eluted with a linear gradient of deionized
water and 100% acetonitrile (0–100%) containing 0.05%
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trifluoroacetic acid (Fisher Scientific, Hampton, NH). The
signal intensity was monitored at 214 nm. As external
standards, polymyxin B sulfate (Sigma, St. Louis, MO) and
colistin sulfate salt (polymyxin E; Sigma) solutions were
prepared in sterile deionized water (1000UmL1) and
injected onto the same reverse-phase (RP)-HPLC system
under the same conditions as described above.
Electrospray ionization (ESI)-MS
The RP-HPLC-purified active compound from P. polymyxa
TH13 was collected and lyophilized to perform further
chemical characterization of the antimicrobial compound.
MS was conducted to determine the molecular mass of the
purified compound at Proteomics and Mass Spectrometry,
Donald Danforth Plant Science Center (St. Louis, MO). The
compound was analyzed on an ABI QSTAR XL (Applied
Biosystems/MDS Sciex) hybrid quadrupole time-of-flight
(qTOF) MS system with a nanoelectrospray source.
Activity assay of partially purified
antibacterial compound
The 80% saturated ammonium sulfate precipitant was
assayed for its antibacterial activity using the well-diffusion
method (Ahn & Stiles, 1990). One hundred microliters of
the precipitant was loaded into a well (8mm in diameter) of
a TSA plate and allowed to absorb into the agar. Five
milliliters of soft ATCC medium 540 [0.75% (w/v) agar]
inoculated with 50 mL of P. larvae ssp. larvae ATCC 9545
overnight culture was overlaid onto the TSA plate contain-
ing the precipitant and incubated at 30 1C until the zone of
inhibition was observed.
Inhibition spectrum of the producer strain
The producer bacterium (TH13) was replica plated onto
TSA plates and incubated at 30 1C for 48 h. The indicator
strains (Table 1), including food spoilage and pathogenic
bacteria, were inoculated in TSB and incubated at 30 or
37 1C according to their optimal growth temperature. Fifty
microliters of overnight culture of the bacterial indicator
strains was mixed with TSA soft agar [0.75% (w/v) agar] and
the mixture was overlaid on the prepared plates to deter-
mine the antibacterial activity of the producer strain. As for
P. larvae ssp. larvae ATCC 9545 and 25747, the activity
assays were performed as described in the previous section.
The overlaid plates were incubated at 30 or 37 1C according
to the optimal growth temperatures of the individual
indicators until the indicators had grown completely. Anti-
microbial activity was measured by designating 1 to
11111 for a range of the lowest to the highest activity,
with the results of the arbitrary estimation of the inhibition
zone size (diameter in mm) formed.
Results
Isolation and identification of the producers
Among the collection of bacterial isolates from US domestic
honey samples, one bacterium (TH13) exhibited the highest
level of antibacterial activity against P. larvae ssp. larvae
ATCC 9545 and was selected for further characterization of
the antibacterial compound. The TH13 strain was a short
rod-shaped, Gram-positive bacterium and was determined
to be P. polymyxa by the NCBI BLAST homology search with
the results of 16S rRNA gene sequencing. The producer
strain was named P. polymyxa TH13.
Table 1. Antibacterial spectrum of Paenibacillus polymyxa TH13
Indicator strains
Producer strain
P. polymyxa TH13
Bacillus cereus F4552 1111
Bacillus cereus ATCC 14579 111
Bacillus subtilis ATCC 23857 1111
Bacillus subtilis CU1065 111
Bacillus subtilis CU1065 (sig neg) 1111
Bacillus subtilis JH642 (1A96) 111
Bacillus subtilis 168 (BGSC no1A1) 
Bacillus licheniformis ATCC 14580 
Paenibacillus larvae ssp. larvae ATCC 25747 11111
Paenibacillus larvae ssp. larvae ATCC 9545 11111
Listeria monocytogenes 104035 11111
Listeria monocytogenes F2 582 1053 11111
Listeria innocua 
Staphylococcus aureus ATCC 9144 11
Staphylococcus aureus ATCC 25923 
Bordetella bronchiseptica ATCC 4617 11111
E. coli BF2 11111
E. coli ATCC 25922 1111
E. coli O157:H7 ATCC 33150 1
E. coli O157:H7 933 11
E. coli O157:H7 ATCC 43889 11111
E. coli O157:H7 ATCC 43895 11
Salmonella Typhimurium ATCC 14028 1111
Salmonella Hartford H0778 1111
Salmonella Gaminara H0662 
Salmonella Rubislaw F2883 
Yersinia enterocolitica 
Klebsiella pneumoniae TR154 1111
Shigella sonnei 1111
Erwinia amylovora SW-2 
Pseudomonas putida FSL D3375 
Pseudomonas aeruginosa ATCC 10145 11
Pseudomonas syringae pv. syringae B301D 111
Pseudomonas fluorescens ATCC 11150 11
Paenibacillus polymyxa TH13 was spotted onto TSA medium and was
assayed to determine the antibacterial activity by deferred inhibition
assay. Antibacterial activity was graded from 1 (lowest) to 11111
(highest activity).
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Antibacterial activity and spectrum of
P. polymyxa TH13
The antimicrobial production of P. polymyxa TH13 was
determined by two methods: deferred inhibition and well-
diffusion methods. Paenibacillus polymyxa TH13 (Fig. 1a)
and 80% ammonium sulfate precipitate of the culture
supernatant (Fig. 1b) exhibited high levels of antibacterial
activity against P. larvae ssp. larvae ATCC 9545.
Paenibacillus polymyxa TH13 exhibited the highest activ-
ity against most Bacillus spp. and two P. larvae ssp. larvae
strains (Table 1). Paenibacillus polymyxa TH13 also exhib-
ited a broad range of inhibition to Gram-negative human
pathogenic bacteria including Bordetella bronchiseptica
ATCC 4617, several Escherichia coli O157:H7 strains, Pseu-
domonas spp. and Klebsiella pneumoniae TR154. In addition,
the growth of Gram-positive bacteria including food spoi-
lage and pathogenic bacteria, such as Bacillus cereus strains
and two Listeria monocytogenes strains, were strongly in-
hibited. However, staphylococci were only slightly inhibited
or resistant to P. polymyxa TH13.
Purification of the antibacterial compounds
The antibacterial activity was detected in the cell-free culture
supernatant after 24-h incubation in TSB. The centrifuged
culture broth was precipitated by ammonium sulfate, which
yielded 4 90% recovery of the activity. The compound
from P. polymyxa TH13 was purified by two steps of column
chromatography. Using CM-sepharose, 4 90% of the activ-
ity from the previous step was eluted with 0.5M NaCl in
buffer A. The fractionated active compound from the cation
exchange chromatography was injected onto the RP-HPLC
system to obtain the purified compound. The chromato-
gram of RP-HPLC resulted in a single peak retaining the
antibacterial activity (Fig. 2b) and the activity of the purified
antimicrobial compound was confirmed by well-diffusion
assay (data not shown).
Molecular mass determination
The HPLC-purified antibacterial compound produced by
P. polymyxa TH13 was characterized by ESI-qTOF MS and
the molecular mass of the peptide was calculated to be
1168.78Da (Fig. 3a). Comparison with all known antimi-
crobial compounds produced by P. polymyxa and other
Bacillus spp. revealed that the molecular mass was identical
to that of polymyxin E1 (Fig. 3b; 1168.77Da).
Discussion
AFB is a catastrophic disease, resulting in considerable
economic loss to the honey industry. In this study, we
attempted to screen bacterial strains isolated from honey
for the production of antibacterial compounds targeting
P. larvae ssp. larvae as potential protective cultures against
Fig. 1. Deferred inhibition assay of Paenibacillus polymyxa TH13 strain
(a) and well-diffusion assay of 80% ammonium sulfate precipitate of
P. polymyxa TH13 culture supernatant (b) against Paenibacillus larvae
ssp. larvae ATCC 9545.
Fig. 2. Chromatogram of colistin sulfate salt (polymyxin E) (a) and CM-
sepharose Fast Flow active fraction on RP-HPLC (b) with a C18 column by
the gradient of deionized water and acetonitrile as the mobile phase.
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AFB. For the characterization of the antimicrobial com-
pounds produced by P. polymyxa TH13, polymyxin B sulfate
and colistin sulfate were analyzed as external standards on
RP-HPLC to compare the retention time of their major
peaks with that of the purified antimicrobial compound.
The chromatogram of polymyxin B sulfate did not show any
peak eluting at the same retention time as that of the purified
compound from P. polymyxa TH13 (data not shown). How-
ever, one of the major peaks from the colistin sulfate solution
injection (Fig. 2a; peak B) was eluted at 21.6min, the same
retention time as that of the purified compound (Fig. 2b).
The HPLC results were confirmed by the result of MS; the
molecular mass of the compound exactly matched with that
of polymyxin E1, 1168.77Da (Li et al., 2001).
Identification of select bacterial strains from the screening
showed a high incidence of P. polymyxa that exhibited strong
antimicrobial activity against P. larvae ssp. larvae. Paeniba-
cilli have been known to produce polymyxins with broad
spectrums of activity that includes Gram-negative as well as
Gram-positive pathogenic bacteria (Storm et al., 1977).
More than 15 polymyxins, including polymyxins B, E, M,
and their derivatives, have been identified. Polymyxins are
classified as peptide antibiotics synthesized by multienzyme
complexes, assembling each amino acid and fatty acid
moiety step-wise into the chemical structure. Polymyxins
are known to bind to lipid A of the bacterial cell membrane,
resulting in membrane disruption and causing cell death
(Martin et al., 2003). Polymyxins have been reported to
exhibit nephrotoxicity and neurotoxicity, which limits the
direct application of the purified compounds to apiaries due
to possible residues being carried over into the honey.
However, polymyxins have been recently reevaluated as
good candidates to treat multidrug-resistant pathogens,
including Pseudomonas aeruginosa, and were described to
be less toxic than had been reported previously (Li et al.,
2005; Falagas & Kasiakou, 2006).
The population of bacterial strains in finished honey is
influenced by the environment during nectar collection and
the resident bacterial microbiota in hives as well as honeybee
sacs, where honey is matured through dehydration. During
honey maturation, the microbiota of honey are subjected to
different types of stresses, including osmotic pressure,
acidity, hydrogen peroxide and phytochemicals, which se-
lects for microorganisms that are able to survive these
stresses. Paenibacillus polymyxa TH13 is a spore-forming
bacterium, capable of surviving the harsh conditions. There-
fore, P. polymyxa TH13 may be a promising candidate as a
protective strain for honeybee larvae and pupae against AFB.
In this study, the honey microbiota was shown to inhibit the
growth of the causative agent of AFB. The use of protective
cultures isolated from healthy hives could have potential
application in apiaries that are prone to AFB, to prevent
or control the incidence of AFB. Consequently, balanced
populations of microbiota producing antimicrobial com-
pounds active against P. larvae ssp. larvae in hives as a
barrier against AFB may reduce the need for antibiotic
treatments.
To our knowledge, this is the first report that identifies an
antimicrobial compound produced by a bacterial strain
from honey that is capable of inhibiting P. larvae ssp. larvae.
The identification of indigenous bacterial strains that ex-
hibit high antimicrobial activity against P. larvae ssp. larvae
is the first step towards the ultimate goal of providing
protection against AFB and potentially lessening the inci-
dence of extraneous antibiotics found in honey.
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Fig. 3. ESI-qTOF mass spectrum of the purified
antibacterial peptide from Paenibacillus polymyxa
TH13 (a), and the chemical structure of
polymyxin E (b). In (b), DAB is a,g-diaminobutyric
acid and fatty acid represents 6-methyloctanoic
acid (polymyxin E1) or 6-methylheptanoic acid
(polymyxin E2).
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